Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Wages, Salaries and Other

Candel Therapeutics (CADL) Long-Term Debt Issuances (2022)

Candel Therapeutics' Long-Term Debt Issuances history spans 1 years, with the latest figure at $19.9 million for Q1 2022.

On a quarterly basis, Long-Term Debt Issuances changed N/A to $19.9 million in Q1 2022 year-over-year; TTM through Dec 2022 was $19.9 million, a N/A change, with the full-year FY2025 number at $47.9 million, changed N/A from a year prior.
Long-Term Debt Issuances hit $19.9 million in Q1 2022 for Candel Therapeutics.
Over the last five years, Long-Term Debt Issuances for CADL hit a ceiling of $19.9 million in Q1 2022 and a floor of $19.9 million in Q1 2022.